Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fatty acid amide hydrolase C385A polymorphism affects susceptibility to various diseases.

BioFactors (Oxford, England) - 1 Jan 2023

Hosseinzadeh Anvar Leila, Ahmadalipour Ali

Abstract excerpt

The endocannabinoid (eCB) system is an important neuromodulatory system with its extensive network of receptors throughout the human body that has complex actions in the nervous system, immune system, and all of the body's other organs. Fatty acid amide hydrolase (FAAH) is an important membrane-bound homodimeric degrading enzyme that controls the biological activity of N-arachidonoylethanolamide (AEA) in the eCB...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amidohydrolases
Share to Endocannabinoids
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 36300805
DOI: 10.1002/biof.1911

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fatty acid amide hydrolase C385A polymorphism affects susceptibility to various diseases.PMID 36300805Read ↗

Association between the FAAH C385A variant (rs324420) and obesity-related traits: a systematic review.Semantic proximity Read ↗

The study of rs324420 (C385A) polymorphism of the FAAH gene of the endocannabinoid system in patients with epilepsy and ADHD.Semantic proximity Read ↗

Relation of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) with obesity and insulin resistance.Semantic proximity Read ↗

Genetic variation in fatty acid amide hydrolase (FAAH): Associations with early drinking and smoking behaviors.Semantic proximity Read ↗

Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance.Semantic proximity Read ↗

A missense mutation in human fatty acid amide hydrolase associated with problem drug use.Semantic proximity Read ↗

C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2.Semantic proximity Read ↗

Genetic variation in the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and their influence on weight loss and insulin resistance under a high monounsaturated fat hypocaloric diet.Semantic proximity Read ↗

[C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and adipocytokine levels in the morbidly obese].Semantic proximity Read ↗

The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects.Semantic proximity Read ↗

Genetic polymorphisms of the endocannabinoid system in obesity and diabetes.Semantic proximity Read ↗

The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: studies of drug use and dependence in Caucasians.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.